415 related articles for article (PubMed ID: 21143798)
1. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.
Grover A; Shandilya A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S15. PubMed ID: 21143798
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
3. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".
Yang H; Shi G; Dou QP
Mol Pharmacol; 2007 Feb; 71(2):426-37. PubMed ID: 17093135
[TBL] [Abstract][Full Text] [Related]
4. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
[TBL] [Abstract][Full Text] [Related]
5. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
[TBL] [Abstract][Full Text] [Related]
6. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.
Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK
Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225
[TBL] [Abstract][Full Text] [Related]
7. Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo.
Yang H; Wang Y; Cheryan VT; Wu W; Cui CQ; Polin LA; Pass HI; Dou QP; Rishi AK; Wali A
PLoS One; 2012; 7(8):e41214. PubMed ID: 22912669
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.
Chen D; Dou QP
Curr Protein Pept Sci; 2010 Sep; 11(6):459-70. PubMed ID: 20491623
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis.
Lu L; Shi W; Deshmukh RR; Long J; Cheng X; Ji W; Zeng G; Chen X; Zhang Y; Dou QP
PLoS One; 2014; 9(11):e113783. PubMed ID: 25419573
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells.
Li X; Zhu F; Jiang J; Sun C; Zhong Q; Shen M; Wang X; Tian R; Shi C; Xu M; Peng F; Guo X; Hu J; Ye D; Wang M; Qin R
Autophagy; 2016 Sep; 12(9):1521-37. PubMed ID: 27308733
[TBL] [Abstract][Full Text] [Related]
12. [The proteasome - structural aspects and inhibitors: a second life for a validated drug target].
Reboud-Ravaux M
Biol Aujourdhui; 2021; 215(1-2):1-23. PubMed ID: 34397372
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Binding Affinity of Novel Syringic Acid Analogues and Critical Determinants of Selectivity as Potent Proteasome Inhibitors.
Cheemanapalli S; Anuradha CM; Madhusudhana P; Mahesh M; Raghavendra PB; Kumar CS
Anticancer Agents Med Chem; 2016; 16(11):1496-1510. PubMed ID: 27173965
[TBL] [Abstract][Full Text] [Related]
14. Withaferin A induces proteasome inhibition, endoplasmic reticulum stress, the heat shock response and acquisition of thermotolerance.
Khan S; Rammeloo AW; Heikkila JJ
PLoS One; 2012; 7(11):e50547. PubMed ID: 23226310
[TBL] [Abstract][Full Text] [Related]
15. [Ubiquitin-independent protein degradation in proteasomes].
Buneeva OA; Medvedev AE
Biomed Khim; 2018 Mar; 64(2):134-148. PubMed ID: 29723144
[TBL] [Abstract][Full Text] [Related]
16. Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies.
Dom M; Offner F; Vanden Berghe W; Van Ostade X
J Proteomics; 2018 May; 179():17-29. PubMed ID: 29448055
[TBL] [Abstract][Full Text] [Related]
17. Uraemic serum induces dysfunction of vascular endothelial cells: role of ubiquitin-proteasome pathway.
Feng B; Zhang YQ; Mu J; Yuan FH; Ye ZL; Qi W; Guo YH; Zeng W; Luo ZF
Exp Physiol; 2011 Aug; 96(8):801-15. PubMed ID: 21602294
[TBL] [Abstract][Full Text] [Related]
18. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.
Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC
Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401
[TBL] [Abstract][Full Text] [Related]
19. Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A.
Grover A; Agrawal V; Shandilya A; Bisaria VS; Sundar D
BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S22. PubMed ID: 22373101
[TBL] [Abstract][Full Text] [Related]
20. Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.
Chen X; Wu J; Yang Q; Zhang X; Zhang P; Liao S; He Z; Wang X; Zhao C; Liu J
Biometals; 2018 Feb; 31(1):29-43. PubMed ID: 29098502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]